welcome
CNBC

CNBC

Health

Health

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

CNBC
Summary
Nutrition label

77% Informative

Novo Nordisk says its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial.

The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo.

The Danish drugmaker presented the results at the American College of Cardiology's Annual Scientific Session in Chicago .

The data suggests that patients who are hesitant to take injections, such as those who are afraid of needles, could soon access treatment in a more convenient way.

VR Score

85

Informative language

91

Neutral language

52

Article tone

formal

Language

English

Language complexity

63

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.